Literature DB >> 19289455

Treatment-resistant depression and mortality after acute coronary syndrome.

Robert M Carney1, Kenneth E Freedland.   

Abstract

Depression is a risk factor for morbidity and mortality in patients with coronary heart disease, especially following acute coronary syndrome. Evidence from recent clinical trials suggests that treatment-resistant depression may be associated with a particularly high risk of mortality or cardiac morbidity in patients following acute coronary syndrome. This article reviews this evidence and considers possible explanations for this relationship. Directions for future research are also considered, with particular emphasis on efforts to elucidate the underlying mechanisms and to develop more efficacious treatments for depression in patients with coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19289455      PMCID: PMC3465939          DOI: 10.1176/appi.ajp.2008.08081239

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  52 in total

1.  Changes in cardiac autonomic control during nocturnal repetitive oxygen desaturation episodes in patients with coronary artery disease.

Authors:  C Keyl; P Lemberger; G Rödig; M Dambacher; A W Frey
Journal:  J Cardiovasc Risk       Date:  1996-04

Review 2.  Cardiovascular effects of n-3 fatty acids.

Authors:  A Leaf; P C Weber
Journal:  N Engl J Med       Date:  1988-03-03       Impact factor: 91.245

3.  Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response.

Authors:  Younger W-Y Yu; Tai-Jui Chen; Chen-Jee Hong; Hung-Mei Chen; Shih-Jen Tsai
Journal:  Neuropsychopharmacology       Date:  2003-04-02       Impact factor: 7.853

4.  MRI-defined vascular depression.

Authors:  K R Krishnan; J C Hays; D G Blazer
Journal:  Am J Psychiatry       Date:  1997-04       Impact factor: 18.112

5.  Sertraline treatment of major depression in patients with acute MI or unstable angina.

Authors:  Alexander H Glassman; Christopher M O'Connor; Robert M Califf; Karl Swedberg; Peter Schwartz; J Thomas Bigger; K Ranga Rama Krishnan; Louis T van Zyl; J Robert Swenson; Mitchell S Finkel; Charles Landau; Peter A Shapiro; Carl J Pepine; Jack Mardekian; Wilma M Harrison; David Barton; Michael Mclvor
Journal:  JAMA       Date:  2002-08-14       Impact factor: 56.272

Review 6.  Definition and epidemiology of treatment-resistant depression.

Authors:  M Fava; K G Davidson
Journal:  Psychiatr Clin North Am       Date:  1996-06

7.  Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study.

Authors:  Robert M Carney; James A Blumenthal; Kenneth E Freedland; Marston Youngblood; Richard C Veith; Matthew M Burg; Carol Cornell; Patrice G Saab; Peter G Kaufmann; Susan M Czajkowski; Allan S Jaffe
Journal:  Psychosom Med       Date:  2004 Jul-Aug       Impact factor: 4.312

8.  Worsening of depressive symptoms 6 months after an acute coronary event in older adults is associated with impairment of cardiac autonomic function.

Authors:  M Soledad Ladrón de Guevara; Silvina I Schauffele; Leonardo C Nicola-Siri; Rodolfo D Fahrer; Enrique Ortíz-Frágola; José A Martínez-Martínez; Daniel P Cardinali; Salvador M Guinjoan
Journal:  J Affect Disord       Date:  2004-06       Impact factor: 4.839

9.  Long-term outcome of episodes of major depression. Clinical and public health significance.

Authors:  M B Keller; G L Klerman; P W Lavori; W Coryell; J Endicott; J Taylor
Journal:  JAMA       Date:  1984-08-10       Impact factor: 56.272

10.  Cortisol and treatment of depression: predictive value of spontaneous and suppressed cortisol levels and course of spontaneous plasma cortisol.

Authors:  P Christensen; A Lolk; L F Gram; P Kragh-Sørensen; O L Pedersen; S Nielsen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

View more
  40 in total

1.  Effect of obstructive sleep apnea on response to cognitive behavior therapy for depression after an acute myocardial infarction.

Authors:  Kenneth E Freedland; Robert M Carney; Junichiro Hayano; Brian C Steinmeyer; Rebecca L Reese; Annelieke M Roest
Journal:  J Psychosom Res       Date:  2012-01-28       Impact factor: 3.006

Review 2.  Depression in patients with heart disease: the case for more trials.

Authors:  Stanley S Liu; Roy C Ziegelstein
Journal:  Future Cardiol       Date:  2010-07

3.  Advances in the Management of Treatment-Resistant Depression.

Authors:  Paul E Holtzheimer
Journal:  Focus (Am Psychiatr Publ)       Date:  2010

Review 4.  Depression and cardiovascular disease: selected findings, controversies, and clinical implications from 2009.

Authors:  Karina W Davidson; Maya Rom Korin
Journal:  Cleve Clin J Med       Date:  2010-07       Impact factor: 2.321

5.  Clinical predictors of depression treatment outcomes in patients with coronary heart disease.

Authors:  Robert M Carney; Kenneth E Freedland; Brian C Steinmeyer; Eugene H Rubin; Michael W Rich
Journal:  J Psychosom Res       Date:  2016-07-19       Impact factor: 3.006

6.  Depression, antidepressant use and mortality in later life: the Health In Men Study.

Authors:  Osvaldo P Almeida; Helman Alfonso; Graeme J Hankey; Leon Flicker
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

7.  Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in mice.

Authors:  Elsa Isingrini; Vincent Camus; Anne-Marie Le Guisquet; Maryse Pingaud; Séverine Devers; Catherine Belzung
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

8.  The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes.

Authors:  Jeff C Huffman; Christopher M Celano; James L Januzzi
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

9.  Changes in cognitive versus somatic symptoms of depression and event-free survival following acute myocardial infarction in the Enhancing Recovery In Coronary Heart Disease (ENRICHD) study.

Authors:  Annelieke M Roest; Robert M Carney; Kenneth E Freedland; Elisabeth J Martens; Johan Denollet; Peter de Jonge
Journal:  J Affect Disord       Date:  2013-03-11       Impact factor: 4.839

10.  Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults.

Authors:  Robert H Howland
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-16       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.